BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9357546)

  • 1. Normal telomere maintenance in immortal ataxia telangiectasia cell lines.
    Sprung CN; Bryan TM; Reddel RR; Murnane JP
    Mutat Res; 1997 Oct; 379(2):177-84. PubMed ID: 9357546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
    Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
    Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells.
    Pandita TK; Pathak S; Geard CR
    Cytogenet Cell Genet; 1995; 71(1):86-93. PubMed ID: 7606935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of ATM function on interactions between telomeres and nuclear matrix.
    Pandita TK; Dhar S
    Radiat Res; 2000 Aug; 154(2):133-9. PubMed ID: 10931683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced telomere length in ataxia-telangiectasia fibroblasts.
    Xia SJ; Shammas MA; Shmookler Reis RJ
    Mutat Res; 1996 Sep; 364(1):1-11. PubMed ID: 8814333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome end-to-end associations and telomerase activity during cancer progression in human cells after treatment with alpha-particles simulating radon progeny.
    Pandita TK; Hall EJ; Hei TK; Piatyszek MA; Wright WE; Piao CQ; Pandita RK; Willey JC; Geard CR; Kastan MB; Shay JW
    Oncogene; 1996 Oct; 13(7):1423-30. PubMed ID: 8875980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit.
    Bryan TM; Marusic L; Bacchetti S; Namba M; Reddel RR
    Hum Mol Genet; 1997 Jun; 6(6):921-6. PubMed ID: 9175740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of ATM function on telomere metabolism.
    Smilenov LB; Morgan SE; Mellado W; Sawant SG; Kastan MB; Pandita TK
    Oncogene; 1997 Nov; 15(22):2659-65. PubMed ID: 9400992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated telomere shortening in ataxia telangiectasia.
    Metcalfe JA; Parkhill J; Campbell L; Stacey M; Biggs P; Byrd PJ; Taylor AM
    Nat Genet; 1996 Jul; 13(3):350-3. PubMed ID: 8673136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
    Cerone MA; Autexier C; LondoƱo-Vallejo JA; Bacchetti S
    Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
    Grobelny JV; Kulp-McEliece M; Broccoli D
    Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of telomeres in SV40-transformed pre-immortal and immortal human fibroblasts.
    Small MB; Hubbard K; Pardinas JR; Marcus AM; Dhanaraj SN; Sethi KA
    J Cell Physiol; 1996 Sep; 168(3):727-36. PubMed ID: 8816928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere length dynamics in telomerase-positive immortal human cell populations.
    Bryan TM; Englezou A; Dunham MA; Reddel RR
    Exp Cell Res; 1998 Mar; 239(2):370-8. PubMed ID: 9521855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
    Fasching CL; Bower K; Reddel RR
    Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxia telangiectasia mutated (Atm) is not required for telomerase-mediated elongation of short telomeres.
    Feldser D; Strong MA; Greider CW
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2249-51. PubMed ID: 16467146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate chromosomal regions for genes involved in activation of alternative lengthening of telomeres in human immortal cell lines.
    Shigeeda N; Uchida M; Barrett JC; Tsutsui T
    Exp Gerontol; 2003 Jun; 38(6):641-51. PubMed ID: 12814799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of immortal normal and ataxia telangiectasia fibroblast cell lines by introduction of the hTERT gene.
    Nakamura H; Fukami H; Hayashi Y; Kiyono T; Nakatsugawa S; Hamaguchi M; Ishizaki K
    J Radiat Res; 2002 Jun; 43(2):167-74. PubMed ID: 12238331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of retinoblastoma in the absence of telomerase activity.
    Gupta J; Han LP; Wang P; Gallie BL; Bacchetti S
    J Natl Cancer Inst; 1996 Aug; 88(16):1152-7. PubMed ID: 8757195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immortalized cells with no detectable telomerase activity. A review.
    Reddel RR; Bryan TM; Murnane JP
    Biochemistry (Mosc); 1997 Nov; 62(11):1254-62. PubMed ID: 9467849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53-dependent chromosome instability is associated with transient reductions in telomere length in immortal telomerase-positive cell lines.
    Schwartz JL; Jordan R; Liber H; Murnane JP; Evans HH
    Genes Chromosomes Cancer; 2001 Mar; 30(3):236-44. PubMed ID: 11170280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.